W. Marston Linehan

机构：Harvard University, Center for Cancer Research · ORCID：0000-0001-7983-3109

发表论文 469 篇 · 总被引 33897 次 · h-index 77

代表论文

• Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors (2025 · Annals of Oncology · 被引 57)
• Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study (2025 · The Lancet Oncology · 被引 35)
• GUK1 activation is a metabolic liability in lung cancer (2025 · Cell · 被引 20)
• Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma (2025 · Nature Communications · 被引 14)
• Evolution of first versus next-line targeted therapies for metastatic non-small cell lung cancer (2025 · Trends in cancer · 被引 7)
• Phase 2 Trial of Consolidative Stereotactic Body Radiation Therapy in Patients With Metastatic Oncogene-driven Non-small Cell Lung Carcinoma Treated With Tyrosine Kinase Inhibitors (2024 · International Journal of Radiation Oncology*Biology*Physics · 被引 7)